IP Group
Investor profile
Deals
27
distinct rounds
Companies
23
backed
Active span
2018–2026
9 yrs
Total round €
€804M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Parkwalk Advisors10
- Hostplus4
- Octopus Ventures3
- Tencent3
- AlbionVC2
- BGF2
- Bloc Ventures2
- British Patient Capital2
- Cambridge Enterprise2
- IQ Capital2
- Mercia Ventures2
- Oxford Science Enterprises2
- Oxford Technology and Innovations EIS Fund (OTIF)2
- Panakès Partners2
- Swisscom Ventures2
- UCL Technology Fund2
- Amadeus Capital Partners1
- Ananda Impact Ventures1
- AXA XL1
- Bits x Bites Growth Fund1
- Braavos Capital1
- Breakthrough Energy Discovery1
- Breakthrough Energy Ventures1
- British Patient Capital’s “Future Fund: Breakthrough”1
- Calderion1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Oxford Nanopore Technologies | UK | 1 | €228M |
| Ultraleap | UK | 1 | €72M |
| Microbiotica | UK | 1 | €61M |
| Quantum Motion | UK | 1 | €47M |
| Ieso | UK | 1 | €47M |
| Bramble Energy | UK | 1 | €42M |
| moa Technology Limited | UK | 1 | €41M |
| First Light Fusion | UK | 1 | €40M |
| AccelerComm | UK | 2 | €38M |
| Mantle8 | France | 1 | €31M |
| Enterprise Therapeutics | UK | 1 | €30M |
| Oxbotica | UK | 1 | €16M |
| Slamcore | UK | 1 | €15M |
| Alesi Surgical | Ireland | 2 | €14M |
| DiffBlue | UK | 2 | €14M |
| MISSION Therapeutics | UK | 1 | €11M |
| Barocal | UK | 2 | €10M |
| GripAble | UK | 1 | €10M |
| Lumai | UK | 1 | €9.2M |
| Vytal | Germany | 1 | €9.1M |
| Deep Render | UK | 1 | €8.3M |
| Intrinsic | UK | 1 | €7.9M |
| Arkivum | UK | 1 | €1.8M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Oxford Nanopore Technologies | Other | €228M | 2021-05 |
| Ultraleap | Series D+ | €72M | 2021-11 |
| Microbiotica | Series B | €61M | 2022-03 |
| Quantum Motion | Series B | €47M | 2023-02 |
| Ieso | Series B | €47M | 2021-11 |
| Bramble Energy | Other | €42M | 2022-02 |
| moa Technology Limited | Series B | €41M | 2022-06 |
| First Light Fusion | Series C | €40M | 2022-02 |
| Mantle8 | Series A | €31M | 2026-05 |
| Enterprise Therapeutics | Series B | €30M | 2024-01 |